Get started
Author

Tania M. Valencia

OpenAlex ID: A5109717294
RGLS4326 Increases Urinary PC1 and PC2 Levels in Individuals with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
2021 · Edmund Lee, Tania M. Valencia, et al. · Journal of the American Society of Nephrology · 5
Farabursen Increases Urinary Polycystin-1 and Polycystin-2 and Reduces Height-Adjusted Total Kidney Volume Growth in Patients with ADPKD
2025 · Alan S.L. Yu, Rekha Garg, et al. · Journal of the American Society of Nephrology · 2
RGLS8429-Mediated miR-17 Inhibition Leads to Acute PKD1/2 De-repression and Ameliorates Preclinical ADPKD
2024 · Ronak Lakhia, Jesus A. Alvarez, et al. · Journal of the American Society of Nephrology · 2
RGLS8429 Increases Urinary PC1 and PC2 and May Reduce Height-Adjusted Total Kidney Volume (htTKV) in Patients with ADPKD
2024 · Alan S.L. Yu, Rekha Garg, et al. · Journal of the American Society of Nephrology · 2
Wcn26-7987 Farabursen Increases Urinary Polycystin 1 and 2 and Reduces Height-adjusted Total Kidney Volume Growth in Patients With Autosomal Dominant Polycystic Kidney Disease
2026 · Alan S. Yu, Rekha Garg, et al. · Kidney International Reports
Discovery of Next-Generation Anti-miR-17 Oligonucleotide RGLS8429 for Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
2022 · Edmund Lee, Tania M. Valencia, et al. · Journal of the American Society of Nephrology
Works count: 6
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type